Jane Street’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.81M Sell
804,589
-229,640
-22% -$2.19M ﹤0.01% 3059
2025
Q4
$12.6M Buy
1,034,229
+680,417
+192% +$8.26M ﹤0.01% 2052
2025
Q3
$4.14M Buy
353,812
+243,340
+220% +$2.91M ﹤0.01% 3706
2025
Q2
$1.03M Buy
110,472
+5,423
+5% +$42.4K ﹤0.01% 5574
2025
Q1
$770K Buy
+105,049
New +$807K ﹤0.01% 6050
2024
Q4
Sell
-124,542
Closed -$1.22M 10217
2024
Q3
$1.08M Sell
124,542
-69,470
-36% -$573K ﹤0.01% 5722
2024
Q2
$1.33M Sell
194,012
-58,344
-23% -$360K ﹤0.01% 5226
2024
Q1
$2.3M Buy
252,356
+121,251
+92% +$861K ﹤0.01% 3881
2023
Q4
$585K Buy
131,105
+70,741
+117% +$209K ﹤0.01% 6492
2023
Q3
$190K Sell
60,364
-196,904
-77% -$806K ﹤0.01% 7662
2023
Q2
$1.33M Buy
257,268
+140,222
+120% +$834K ﹤0.01% 4777
2023
Q1
$617K Buy
117,046
+89,423
+324% +$425K ﹤0.01% 5959
2022
Q4
$77.6K Buy
27,623
+4,965
+22% +$16.4K ﹤0.01% 8221
2022
Q3
$94K Sell
22,658
-24,286
-52% -$122K ﹤0.01% 8677
2022
Q2
$189K Buy
+46,944
New +$177K ﹤0.01% 8243
2022
Q1
Sell
-16,875
Closed -$118K 10819
2021
Q4
$118K Sell
16,875
-39,682
-70% -$308K ﹤0.01% 9147
2021
Q3
$565K Buy
56,557
+14,262
+34% +$160K ﹤0.01% 7053
2021
Q2
$599K Buy
42,295
+1,049
+3% +$15.9K ﹤0.01% 6902
2021
Q1
$677K Buy
41,246
+5,193
+14% +$100K ﹤0.01% 6230
2020
Q4
$746K Buy
36,053
+5,927
+20% +$88K ﹤0.01% 5134
2020
Q3
$229K Buy
+30,126
New +$250K ﹤0.01% 6261
2020
Q2
Sell
-23,779
Closed -$158K 7418
2020
Q1
$118K Buy
+23,779
New +$117K ﹤0.01% 4881
2018
Q3
Sell
-13,489
Closed -$91K 5526
2018
Q2
$91K Buy
+13,489
New +$92.7K ﹤0.01% 4751

Other funds holding OCUL